Search
for

    Sort by

    Research 451–480 of 1000+

    1. A novel therapeutic paradigm for patients with extensive alopecia areata Expert Opinion on Biological Therapy · 2016 · 30 citations
    2. The Pathogenesis of Alopecia Areata in Rodent Models Journal of Investigative Dermatology Symposium Proceedings · 2003 · 23 citations
    3. Differential proteomics of lesional vs. non-lesional biopsies revealed non-immune mechanisms of alopecia areata Scientific Reports · 2018 · 19 citations
    4. Extensive alopecia areata: Not necessarily recalcitrant to therapy! International Journal of Trichology · 2011 · 14 citations
    5. Quality of Life with Alopecia Areata versus Androgenetic Alopecia Assessed Using Hair Specific Skindex-29 Annals of Dermatology · 2018 · 13 citations
    6. Utility of azathioprine, methotrexate and cyclosporine as steroid‐sparing agents in chronic alopecia areata: a retrospective study of continuation rates in 138 patients 2020 · 12 citations
    7. Preferential Recognition of Hydroxyl Radical-Modified Superoxide Dismutase by Circulating Autoantibodies in Patients with Alopecia Areata Annals of Dermatology · 2014 · 12 citations
    8. Mild-to-moderate COVID-19 is not associated with worsening of alopecia areata: A retrospective analysis of 32 patients Journal of The American Academy of Dermatology · 2021 · 11 citations
    9. Alopecia Areata in the Indian Subcontinent Skinmed · 2007 · 10 citations
    10. Nail involvement in patients with moderate-to-severe alopecia areata treated with oral tofacitinib Journal of Dermatological Treatment · 2018 · 9 citations
    11. Treatment of Severe Alopecia Areata: Combination Therapy Using Systemic Cyclosporine A with Low Dose Corticosteroids Annals of Dermatology · 2008 · 8 citations
    12. Sequential cyclic changes of hair roots revealed by dermoscopy demonstrate a progressive mechanism of diffuse alopecia areata over time Experimental Dermatology · 2018 · 4 citations
    13. Impact of Previous Alopecia Areata Treatment on Efficacy Responses up to Week 48 Following Ritlecitinib Treatment: A Post Hoc Analysis Dermatology and Therapy · 2024 · 3 citations
    14. Oxidative stress and alopecia areata Frontiers in medicine · 2023 · 3 citations
    15. Evaluation of fractional carbon dioxide laser alone versus its combination with betamethasone valerate in treatment of alopecia areata, a clinical and dermoscopic study Archives of dermatological research · 2022 · 3 citations
    16. Stressful lie events in alopecia areata patients: A case control study Our Dermatology Online · 2020 · 2 citations
    17. Retrospective Analysis of Systemic Corticosteroids for Alopecia Areata in Pediatric Patients Dermatology Archives · 2020 · 1 citations
    18. A consensus-based treatment algorithm for alopecia areata in adolescents and adults: integrating severity, quality of life, and disease dynamics Frontiers in Medicine · 2026
    19. Alopecia areata associated with hypothyroidism and sickle cell anemia: Significant hair regrowth within 8 months of homoeopathic treatment at Dr. Batra’s International Journal of Homoeopathic Sciences · 2026
    20. Associated comorbidities in pediatric patients with alopecia areata Boletín Médico Del Hospital Infantil de México (English Edition) · 2026
    21. Efficacy, safety and dose response of STS01, a topical controlled release nanoparticle formulation (dithranol/Prosilic), in adults with mild to moderate patchy alopecia areata: A randomised, double-blind, multicentre, phase 2 trial medRxiv · 2026
    22. Case Report: Multimodal contact immunotherapy in alopecia areata: long-term clinical experience in the JAK inhibitor era Frontiers in Medicine · 2026
    23. EFFICACY OF INTRALESIONAL BOTULINUM TOXIN INJECTION IN THE TREATMENT OF PATCHY ALOPECIA AREATA (AA) BULLETIN OF STOMATOLOGY AND MAXILLOFACIAL SURGERY · 2026
    24. Comparative safety profiles of baricitinib and tofacitinib in the treatment of adult alopecia areata: a pharmacovigilance study based on the FAERS database Frontiers in Public Health · 2026
    25. Baricitinib Provides Higher Efficacy in Adolescents Relative to Adults With Alopecia Areata Despite More Severe Disease at Baseline: 36-Week Outcomes From BRAVE-AA Trials SKIN The Journal of Cutaneous Medicine · 2025
    26. Characterization of thyroid disorders in alopecia areata patients: A cross-sectional evaluation Journal of Skin and Sexually Transmitted Diseases · 2025
    27. Rationale and Design of a Novel, Phase 3, External and Synthetic Placebo-Controlled Clinical Trial of Ritlecitinib 50 mg and 100 mg for Alopecia Areata Dermatology and Therapy · 2025
    28. Baricitinib in the Management of Severe Alopecia Areata: A Report of Two Cases With Sustained Clinical Response Cureus · 2025
    29. Baricitinib for the Treatment of Moderate-to-Severe Alopecia Areata Balkan Medical Journal · 2025
    30. Efficacy and safety of tofacitinib in pediatric patients with alopecia areata: A prospective cohort study International Journal of Dermatology Venereology and Leprosy Sciences · 2025